Questions, Feedback & Help
Send us an email and we'll get back to you ASAP. Or you can read our Frequently Asked Questions.

WormBase Tree Display for Gene: WBGene00006801

expand all nodes | collapse all nodes | view schema

Name Class

WBGene00006801SMapS_parentSequenceCHROMOSOME_V
IdentityVersion2
NameCGC_nameunc-68Person_evidenceWBPerson261
Sequence_nameK11C4.5
Molecular_name (48)
Other_nameryr-1
kra-1
CELE_K11C4.5Accession_evidenceNDBBX284605
Public_nameunc-68
DB_infoDatabase (11)
SpeciesCaenorhabditis elegans
HistoryVersion_change107 Apr 2004 11:29:43WBPerson1971EventImportedInitial conversion from geneace
207 Nov 2007 17:12:59WBPerson2970EventAcquires_mergeWBGene00021962
Acquires_mergeWBGene00021962
StatusLive
Gene_infoBiotypeSO:0001217
Gene_classunc
Reference_alleleWBVar00143286
Allele (351)
Legacy_informationSee also e2313
[Kagawa H] pka ryr-1, for ryanodine receptor. 46 exons, encodes 5071 aa predicted protein. e540 (Unc-68) is intron 21 splice acceptor mutation, probable null. Weak allele kh30 (pka kra-1) exhibits ketamine-dependent convulsions followed by paralysis, mutation is S1444N change at putative PKC phosphorylation site.
[C.elegansII] e540 : weak kinker, slow, thin; slight shrinker; head region but not body resistant to 1 mM levamisole, ouabain. ES3. ME2. OA>15: x14, x24, e932, e2313,s92spo, r1162 (presumed null, deletes all TM domains) etc.(all resemble e540). Cloned: 30 kb gene, 43 exons, encodes 4902 aa ryanodine receptor (43% identity to mammalian cardiac RYR). [Brenner 1974; Lewis et al. 1980; HK; TR]
[C.elegansII] kh30 : semidominant convulsive behavior in 30mM ketamine or other NMDA antagonists; recessive cs Unc; variable motility; weakly resistant to cholinergic agonists, ouabain;normal muscle morphology. [HK]
Complementation_data[Kagawa H] fails to complement kh30 (pka kra-1)
Strain (21)
RNASeq_FPKM (74)
GO_annotation (28)
Ortholog (67)
ParalogWBGene00002173Caenorhabditis elegansFrom_analysisPanther
WormBase-Compara
Structured_descriptionConcise_descriptionunc-68 encodes a ryanodine receptor ortholog that is expressed in body-wall muscle cells and is required for normal body tension and locomotion; unc-68 mutants are flaccid, sluggish, and resistant to ryanodine, but have normal muscle ultrastructure; UNC-68 is dispensable for excitation-contraction coupling itself, but may amplify its calcium signals; the unc-68/kra-1(kh30) mutation is an S1444N substitution at a putative protein kinase C phosphorylation site; UNC-68 reduced unc-103(sy557)-induced spicule protraction by one half; unc-68 is orthologous to the human genes RYR1 (OMIM:180901, mutated in malignant hyperthermia and central core disease), RYR2 (OMIM:180902, mutated in stress-induced polymorphic ventricular tachycardia), and RYR3 (OMIM:180903).Paper_evidenceWBPaper00002536
WBPaper00002749
WBPaper00005799
WBPaper00006125
Curator_confirmedWBPerson1823
WBPerson567
Date_last_updated17 Jun 2004 00:00:00
Automated_descriptionPredicted to enable calcium ion binding activity and ryanodine-sensitive calcium-release channel activity. Involved in locomotion; positive regulation of programmed cell death; and protein localization to organelle. Located in I band and sarcoplasmic reticulum. Expressed in body wall musculature; intestine; neurons; and non-striated muscle. Used to study congenital myopathy 1A and malignant hyperthermia. Human ortholog(s) of this gene implicated in several diseases, including catecholaminergic polymorphic ventricular tachycardia 1; intracranial vasospasm; and muscle tissue disease (multiple). Is an ortholog of human RYR1 (ryanodine receptor 1); RYR2 (ryanodine receptor 2); and RYR3 (ryanodine receptor 3).Paper_evidenceWBPaper00065943
Curator_confirmedWBPerson324
WBPerson37462
Inferred_automaticallyThis description was generated automatically by a script based on data from the WS291 version of WormBase
Date_last_updated29 Nov 2023 00:00:00
Disease_infoExperimental_modelDOID:3529Homo sapiensPaper_evidenceWBPaper00059411
Curator_confirmedWBPerson324
Date_last_updated08 Jun 2021 00:00:00
DOID:8545Homo sapiensPaper_evidenceWBPaper00059411
Curator_confirmedWBPerson324
Date_last_updated08 Jun 2021 00:00:00
Potential_model (12)
Modifies_diseaseDOID:11723
Modifies_disease_in_annotationWBDOannot00000746
Models_disease_asserted (14)
Molecular_infoCorresponding_CDS (16)
Corresponding_CDS_historyK11C4.5:wp166
K11C4.5:wp184
K11C4.5a:wp261
K11C4.5b:wp236
K11C4.5b:wp261
K11C4.5c:wp261
K11C4.5d:wp261
Corresponding_transcript (16)
Other_sequence (63)
Associated_feature (24)
Experimental_infoRNAi_result (20)
Expr_pattern (12)
Drives_constructWBCnstr00006689
WBCnstr00010174
WBCnstr00010354
WBCnstr00010749
WBCnstr00015983
WBCnstr00015984
WBCnstr00039937
WBCnstr00039938
Construct_productWBCnstr00000351
WBCnstr00000352
WBCnstr00006689
WBCnstr00010354
WBCnstr00010749
WBCnstr00014791
WBCnstr00016961
WBCnstr00017064
Antibody (12)
Microarray_results (34)
Expression_cluster (208)
Interaction (56)
Map_infoMapVPosition0.477486Error0.002969
Well_ordered
PositiveInside_rearrsDf20
Positive_cloneK11C4Inferred_automaticallyFrom sequence, transcript, pseudogene data
M04C11
NegativeOutside_rearrnDf31
Negative_cloneM04C11
Mapping_data2_point310
2841
3136
4524
Multi_point (17)
Pos_neg_data (16)
Landmark_gene
Reference (150)
Remarkresults of mutation site, phenotype, rescue appear in J. Mol. Biol. 267, 849-864. 1997 Sakube, Y., Ando, H. & Kagawa H.
MethodGene